Detection rates for abnormal cervical smears: what are we screening for?

The Lancet

Volumn 345, Issue 8963, 1995, Pages 1469-1473

  Raffle, A E ^a   Alden, B ^b   Mackenzie, E F D ^c  

^a Bristol District Health Authority   (United Kingdom)

^b UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

^c NORTH BRISTOL NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER SCREENING; COLPOSCOPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCREENING TEST; UNITED KINGDOM; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY;

EID: 0029641083     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(95)91036-0     Document Type: Article

References (18)

1. Screening for cervical intraepithelial neoplasia in north east Scotland shows fall in incidence and mortality from invasive cancer with concomitant rise in preinvasive disease
2. Quantitative determination of acid-labile DNA in cervical intraepithelial neoplasia
3. Human papillomavirus type 16 DNA in cervical smears as predictor of high-grade cervical cancer
4. Management of women with mild and moderate dyskaryosis
5. Terminology in gynaecological cytopathology: report of the working party of the British Society for Clinical Cytology
6. Mortality from carcinoma of the uterus. An international cohort study
7. Borderline nuclear changes in cervical smears: guidelines on their recognition and management
8. Trends in cervical and breast cancer in Iceland. A statistical evaluation of trends in incidence and mortality for the period 1955-1989, their relation to screening and prediction to the year 2000
9. Mortality from carcinoma of the cervix uteri in Britain
10. Screening for cervical cancer
11. Trends in cervical cancer mortality
12. Long-term follow up of 1121 cases of carcinoma in situ
13. Carcinoma in situ of the cervix. An analysis of 861 patients
14. The invasive potential of carcinoma in situ of the cervix